Anebulo was founded with the intention of developing disruptive treatments for substance use disorders, such as cannabinoid intoxication and the broader addiction landscape.

Pharmaceutical

Anebulo Pharmaceuticals

Simon Allen

Kenneth Cundy

Sandra Gardiner

The executive team at Anebulo Pharmaceuticals have a history of working in the biotech industry and have a wealth of experience in finance and business. They have also worked as consultants for various companies in the biotech industry.

CEO and Executive Team

About

Team members

Other teams at Anebulo Pharmaceuticals

Board of Directors

Leadership Team